John Inge Johnsen Selected Research

4- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamide

1/2016	Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma.
1/2016	Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Inge Johnsen Research Topics

Disease

44	Neoplasms (Cancer) 04/2022 - 08/2006
37	Neuroblastoma 01/2022 - 04/2003
14	Medulloblastoma 04/2022 - 10/2008
4	Carcinogenesis 03/2022 - 01/2010
4	Brain Neoplasms (Brain Tumor) 08/2012 - 10/2008
2	Inflammation (Inflammations) 06/2018 - 01/2012
1	Merkel Cell Carcinoma 03/2022
1	Nervous System Neoplasms (Neoplasms, Nervous System) 01/2020
1	Rhabdomyosarcoma 01/2019
1	Cytomegalovirus Infections (Inclusion Disease) 08/2012
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2012

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 02/2019 - 07/2010
7	Biological ProductsIBA 01/2022 - 10/2005
7	Pharmaceutical PreparationsIBA 12/2019 - 05/2006
6	Dinoprostone (PGE2)FDA Link 04/2022 - 10/2008
5	RNA (Ribonucleic Acid)IBA 04/2022 - 10/2011
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 04/2022 - 05/2006
4	Phosphotransferases (Kinase)IBA 01/2022 - 01/2010
4	Prostaglandin-E SynthasesIBA 01/2020 - 10/2008
4	Small Interfering RNA (siRNA)IBA 02/2019 - 11/2009
4	DNA (Deoxyribonucleic Acid)IBA 08/2014 - 10/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 05/2006
3	rho-Associated KinasesIBA 12/2019 - 03/2016
3	CalciumIBA 11/2017 - 01/2012
3	CateninsIBA 03/2016 - 11/2015
3	Prostaglandins EIBA 01/2012 - 10/2008
3	ProstaglandinsIBA 01/2012 - 10/2008
3	Docosahexaenoic AcidsIBA 04/2011 - 05/2006
2	CytokinesIBA 03/2022 - 11/2017
2	Messenger RNA (mRNA)IBA 12/2019 - 01/2012
2	ChemokinesIBA 11/2017 - 01/2016
2	Complementary DNA (cDNA)IBA 03/2016 - 01/2016
2	Macrophage Colony-Stimulating FactorIBA 01/2016 - 01/2016
2	4- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamideIBA 01/2016 - 01/2016
2	MethyltransferasesIBA 11/2015 - 08/2014
2	Antiviral Agents (Antivirals)IBA 02/2015 - 10/2011
2	4-phenylbutyric acid (Buphenyl)FDA Link 08/2014 - 07/2011
2	Imatinib Mesylate (Gleevec)FDA Link 08/2014 - 03/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2014 - 07/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 10/2011
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2012 - 10/2008
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2012 - 10/2011
2	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2011 - 01/2010
2	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 04/2011 - 03/2010
2	LipidsIBA 03/2010 - 10/2005
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2006 - 10/2005
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2006 - 10/2005
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 04/2022
1	alpha-Linolenic Acid (Linolenic Acid)IBA 04/2022
1	Tumor Viral Antigens (Large T Antigen)IBA 03/2022
1	entrectinibIBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	TropomyosinIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 12/2021
1	SL-176IBA 11/2021
1	nutlin 3IBA 11/2021
1	Long Noncoding RNAIBA 01/2021
1	HhAntag691IBA 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Galectin 1 (LGALS1)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	RKI-1447IBA 12/2019
1	Syk KinaseIBA 02/2019
1	RNA Polymerase I (Polymerase I, RNA)IBA 01/2019
1	NSC 652287IBA 01/2019
1	CX 5461IBA 01/2019
1	GANT 61IBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Checkpoint Kinase 1IBA 01/2017
1	Aurora KinasesIBA 01/2017
1	CalcineurinIBA 01/2016
1	Phospho-Specific AntibodiesIBA 01/2016
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2016
1	Estrogen Receptor alphaIBA 01/2016
1	Blocking AntibodiesIBA 01/2016
1	cyclosporin HIBA 01/2016
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Therapeutic UsesIBA 01/2016
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2016
1	DNA Repair EnzymesIBA 11/2015
1	Temozolomide (Temodar)FDA LinkGeneric 11/2015
1	Histones (Histone)IBA 08/2014
1	tyrosine receptor (receptor, tyrosine)IBA 08/2014
1	Sunitinib (Sutent)FDA Link 01/2014
1	Tissue ExtractsIBA 11/2013
1	TWEAK ReceptorIBA 04/2013
1	Nucleic AcidsIBA 08/2012
1	Cyclic AMP (AMP, Cyclic)IBA 01/2012
1	PI103IBA 12/2011

Therapy/Procedure

23	Therapeutics 01/2022 - 04/2003
5	Drug Therapy (Chemotherapy) 02/2019 - 10/2005
1	Investigational Therapies (Experimental Therapy) 01/2017
1	Immunotherapy 01/2016
1	Combined Modality Therapy 01/2016
1	Heterologous Transplantation (Xenotransplantation) 01/2016